Ullet index:OncoTherapy Science,Inc.:4564

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index OncoTherapy Science,Inc. Go to web site 4564 Medicals 東証グロース March 1, 2000 2003.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

OncoTherapy Science,Inc. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 855
plusdown
1,980
plusdown
3,077
plusdown
4,728
plusdown
4,870
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp -1,119
plusup
-2,572
plusdown
-1,562
plusup
-2,239
plusup
-2,935
plus
Operating Cash Flow(OFC)Help -795
plusup
-2,073
plusdown
-1,763
plusup
-2,276
plusup
-2,373
plus
Free Cash Flow(FCF)Help -815
plusup
-2,541
plusdown
-1,815
plusup
-2,306
plusup
-2,448
plus
OFC - Net IncomeHelp 4
plusdown
10
plusup
6
plusup
-229
plusdown
-12
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -103.77%
plusup
-109.37%
plusdown
-60.72%
plusdown
-50.36%
plusup
-52.07%
plus
Current Assets / Amount of SalesHelp 67.49%
plusdown
164.31%
plusdown
873.09%
plusdown
1,428.90%
plusdown
1,624.65%
plus
Free Cash Revenue RatioHelp -71.83%
plusup
-220.27%
plusup
-545.86%
plusup
-729.32%
plusup
-872.33%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

OncoTherapy Science,Inc.

Company where related level is highHelp

Toyama Chemical Co.,Ltd.
Chiome Bioscience Inc.
Otsuka Holdings Co.,Ltd.
Kubota Pharmaceutical Holdings Co.,Ltd.
NANO MRNA Co., Ltd.
SANTEN PHARMACEUTICAL CO.,LTD.
ASKA Pharmaceutical Co.,Ltd.
ONO PHARMACEUTICAL CO.,LTD.
Carna Biosciences,Inc.
Modalis Therapeutics Corporation